Home » Topics » Regulatory » Patents

Patents
RSS

DKFZ and TUM present EPHA2 inhibitors

Nov. 6, 2018

Magenta Therapeutics patents AhR antagonists

Nov. 6, 2018

Cancer Research Technology identifies RET inhibitors

Nov. 5, 2018

AbbVie patents new BRD4 inhibitors

Nov. 5, 2018

ILDONG Pharmaceutical discovers farnesoid X receptor agonists

Nov. 2, 2018

Roche patents antibacterial macrocyclic oligopeptides

Nov. 2, 2018

Biogen describes new Bruton tyrosine kinase inhibitors

Nov. 2, 2018

Sidecar Therapeutics identifies LOXL2 and MAP3K5 inhibitors

Oct. 26, 2018

U.S. researchers divulge new SCN9A blockers

Oct. 26, 2018

Aerie Pharmaceuticals patents protein kinase inhibitors

Oct. 26, 2018

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...